Burning Rock Biotech Ltd (BNR) › Operating IncomeBurning Rock Biotech Ltd (BNR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -161.40M CNY2019: -169.09M CNY2020: -412.40M CNY2021: -797.06M CNY2022: -980.41M CNY2023: -669.32M CNY2024: -357.56M CNY2025: -54.84M CNY-54.84M CNY2018Operating Income (CNY)2025Fiscal YearOperating IncomeChange YoY2025-54.84M CNY+84.7%2024-357.56M CNY+46.6%2023-669.32M CNY+31.7%2022-980.41M CNY-23.0%2021-797.06M CNY-93.3%2020-412.40M CNY-143.9%2019-169.09M CNY-4.8%2018-161.40M CNY—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share